Literature DB >> 33495759

Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study.

Zhen Zhang1, Qifang Bi2, Shisong Fang3, Lan Wei1, Xin Wang3, Jianfan He4, Yongsheng Wu1, Xiaojian Liu1, Wei Gao5, Renli Zhang3, Wenfeng Gong6, Qiru Su7, Andrew S Azman2, Justin Lessler2, Xuan Zou4.   

Abstract

BACKGROUND: Virological detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through RT-PCR has limitations for surveillance. Serological tests can be an important complementary approach. We aimed to assess the practical performance of RT-PCR-based surveillance protocols and determine the extent of undetected SARS-CoV-2 infection in Shenzhen, China.
METHODS: We did a cohort study in Shenzhen, China and attempted to recruit by telephone all RT-PCR-negative close contacts (defined as those who lived in the same residence as, or shared a meal, travelled, or socially interacted with, an index case within 2 days before symptom onset) of all RT-PCR-confirmed cases of SARS-CoV-2 detected since January, 2020, via contact tracing. We measured anti-SARS-CoV-2 antibodies in serum samples from RT-PCR-negative close contacts 2-15 weeks after initial virological testing by RT-PCR, using total antibody, IgG, and IgM ELISAs. In addition, we did a serosurvey of volunteers from neighbourhoods with no reported cases, and from neighbourhoods with reported cases. We assessed rates of infection undetected by RT-PCR, performance of RT-PCR over the course of infection, and characteristics of individuals who were seropositive on total antibody ELISA but RT-PCR negative.
FINDINGS: Between April 12 and May 4, 2020, we enrolled and collected serological samples from 2345 (53·0%) of 4422 RT-PCR-negative close contacts of cases of RT-PCR-confirmed SARS-CoV-2. 1175 (50·1%) of 2345 were close contacts of cases diagnosed in Shenzhen with contact tracing details, and of these, 880 (74·9%) had serum samples collected more than 2 weeks after exposure to an index case and were included in our analysis. 40 (4·5%) of 880 RT-PCR-negative close contacts were positive on total antibody ELISA. The seropositivity rate with total antibody ELISA among RT-PCR-negative close contacts, adjusted for assay performance, was 4·1% (95% CI 2·9-5·7), which was significantly higher than among individuals residing in neighbourhoods with no reported cases (0·0% [95% CI 0·0-1·1]). RT-PCR-positive individuals were 8·0 times (95% CI 5·3-12·7) more likely to report symptoms than those who were RT-PCR-negative but seropositive, but both groups had a similar distribution of sex, age, contact frequency, and mode of contact. RT-PCR did not detect 48 (36% [95% CI 28-44]) of 134 infected close contacts, and false-negative rates appeared to be associated with stage of infection.
INTERPRETATION: Even rigorous RT-PCR testing protocols might miss a substantial proportion of SARS-CoV-2 infections, perhaps in part due to difficulties in determining the timing of testing in asymptomatic individuals for optimal sensitivity. RT-PCR-based surveillance and control protocols that include rapid contact tracing, universal RT-PCR testing, and mandatory 2-week quarantine were, nevertheless, able to contain community spread in Shenzhen, China. FUNDING: The Bill & Melinda Gates Foundation, Special Foundation of Science and Technology Innovation Strategy of Guangdong Province, and Key Project of Shenzhen Science and Technology Innovation Commission.
© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Entities:  

Mesh:

Year:  2021        PMID: 33495759      PMCID: PMC7816573          DOI: 10.1016/S2666-5247(20)30200-7

Source DB:  PubMed          Journal:  Lancet Microbe        ISSN: 2666-5247


  17 in total

1.  Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study.

Authors:  Rita Christiane Baron; Lorenz Risch; Myriam Weber; Sarah Thiel; Kirsten Grossmann; Nadia Wohlwend; Thomas Lung; Dorothea Hillmann; Michael Ritzler; Susanna Bigler; Konrad Egli; Francesca Ferrara; Thomas Bodmer; Mauro Imperiali; Sonja Heer; Harald Renz; Lukas Flatz; Philipp Kohler; Pietro Vernazza; Christian R Kahlert; Matthias Paprotny; Martin Risch
Journal:  Clin Chem Lab Med       Date:  2020-08-31       Impact factor: 3.694

2.  Temporal dynamics in viral shedding and transmissibility of COVID-19.

Authors:  Xi He; Eric H Y Lau; Peng Wu; Xilong Deng; Jian Wang; Xinxin Hao; Yiu Chung Lau; Jessica Y Wong; Yujuan Guan; Xinghua Tan; Xiaoneng Mo; Yanqing Chen; Baolin Liao; Weilie Chen; Fengyu Hu; Qing Zhang; Mingqiu Zhong; Yanrong Wu; Lingzhai Zhao; Fuchun Zhang; Benjamin J Cowling; Fang Li; Gabriel M Leung
Journal:  Nat Med       Date:  2020-04-15       Impact factor: 53.440

3.  Antibody responses to SARS-CoV-2 in patients with COVID-19.

Authors:  Quan-Xin Long; Bai-Zhong Liu; Hai-Jun Deng; Gui-Cheng Wu; Kun Deng; Yao-Kai Chen; Pu Liao; Jing-Fu Qiu; Yong Lin; Xue-Fei Cai; De-Qiang Wang; Yuan Hu; Ji-Hua Ren; Ni Tang; Yin-Yin Xu; Li-Hua Yu; Zhan Mo; Fang Gong; Xiao-Li Zhang; Wen-Guang Tian; Li Hu; Xian-Xiang Zhang; Jiang-Lin Xiang; Hong-Xin Du; Hua-Wen Liu; Chun-Hui Lang; Xiao-He Luo; Shao-Bo Wu; Xiao-Ping Cui; Zheng Zhou; Man-Man Zhu; Jing Wang; Cheng-Jun Xue; Xiao-Feng Li; Li Wang; Zhi-Jie Li; Kun Wang; Chang-Chun Niu; Qing-Jun Yang; Xiao-Jun Tang; Yong Zhang; Xia-Mao Liu; Jin-Jing Li; De-Chun Zhang; Fan Zhang; Ping Liu; Jun Yuan; Qin Li; Jie-Li Hu; Juan Chen; Ai-Long Huang
Journal:  Nat Med       Date:  2020-04-29       Impact factor: 53.440

4.  Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.

Authors:  Juliet E Bryant; Andrew S Azman; Matthew J Ferrari; Benjamin F Arnold; Maciej F Boni; Yap Boum; Kyla Hayford; Francisco J Luquero; Michael J Mina; Isabel Rodriguez-Barraquer; Joseph T Wu; Djibril Wade; Guy Vernet; Daniel T Leung
Journal:  Sci Immunol       Date:  2020-05-19

5.  The efficacy of medical masks and respirators against respiratory infection in healthcare workers.

Authors:  Chandini Raina MacIntyre; Abrar Ahmad Chughtai; Bayzidur Rahman; Yang Peng; Yi Zhang; Holly Seale; Xiaoli Wang; Quanyi Wang
Journal:  Influenza Other Respir Viruses       Date:  2017-08-30       Impact factor: 4.380

6.  Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.

Authors:  Mayara Lisboa Bastos; Gamuchirai Tavaziva; Syed Kunal Abidi; Jonathon R Campbell; Louis-Patrick Haraoui; James C Johnston; Zhiyi Lan; Stephanie Law; Emily MacLean; Anete Trajman; Dick Menzies; Andrea Benedetti; Faiz Ahmad Khan
Journal:  BMJ       Date:  2020-07-01

7.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.

Authors:  Qifang Bi; Yongsheng Wu; Shujiang Mei; Chenfei Ye; Xuan Zou; Zhen Zhang; Xiaojian Liu; Lan Wei; Shaun A Truelove; Tong Zhang; Wei Gao; Cong Cheng; Xiujuan Tang; Xiaoliang Wu; Yu Wu; Binbin Sun; Suli Huang; Yu Sun; Juncen Zhang; Ting Ma; Justin Lessler; Tiejian Feng
Journal:  Lancet Infect Dis       Date:  2020-04-27       Impact factor: 25.071

8.  Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.

Authors:  Anita S Iyer; Forrest K Jones; Ariana Nodoushani; Jason B Harris; Richelle C Charles; Meagan Kelly; Margaret Becker; Damien Slater; Rachel Mills; Erica Teng; Mohammad Kamruzzaman; Wilfredo F Garcia-Beltran; Michael Astudillo; Diane Yang; Tyler E Miller; Elizabeth Oliver; Stephanie Fischinger; Caroline Atyeo; A John Iafrate; Stephen B Calderwood; Stephen A Lauer; Jingyou Yu; Zhenfeng Li; Jared Feldman; Blake M Hauser; Timothy M Caradonna; John A Branda; Sarah E Turbett; Regina C LaRocque; Guillaume Mellon; Dan H Barouch; Aaron G Schmidt; Andrew S Azman; Galit Alter; Edward T Ryan
Journal:  Sci Immunol       Date:  2020-10-08

9.  False-negative results of initial RT-PCR assays for COVID-19: A systematic review.

Authors:  Ingrid Arevalo-Rodriguez; Diana Buitrago-Garcia; Daniel Simancas-Racines; Paula Zambrano-Achig; Rosa Del Campo; Agustin Ciapponi; Omar Sued; Laura Martinez-García; Anne W Rutjes; Nicola Low; Patrick M Bossuyt; Jose A Perez-Molina; Javier Zamora
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

10.  Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.

Authors:  Juanjuan Zhao; Quan Yuan; Haiyan Wang; Wei Liu; Xuejiao Liao; Yingying Su; Xin Wang; Jing Yuan; Tingdong Li; Jinxiu Li; Shen Qian; Congming Hong; Fuxiang Wang; Yingxia Liu; Zhaoqin Wang; Qing He; Zhiyong Li; Bin He; Tianying Zhang; Yang Fu; Shengxiang Ge; Lei Liu; Jun Zhang; Ningshao Xia; Zheng Zhang
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

View more
  25 in total

1.  Household quarantine of second degree contacts is an effective non-pharmaceutical intervention to prevent tertiary cases in the current SARS-CoV pandemic.

Authors:  Josef A I Weigl; Anna-Katharina Feddersen; Mona Stern
Journal:  BMC Infect Dis       Date:  2021-12-19       Impact factor: 3.090

2.  SARS-CoV-2 Risk Quantification Model and Validation Based on Large-Scale Dutch Test Events.

Authors:  Bas Kolen; Laurens Znidarsic; Andreas Voss; Simon Donders; Iris Kamphorst; Maarten van Rijn; Dimitri Bonthuis; Merit Clocquet; Maarten Schram; Rutger Scharloo; Tim Boersma; Tim Stobernack; Pieter van Gelder
Journal:  Int J Environ Res Public Health       Date:  2022-06-13       Impact factor: 4.614

3.  Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab.

Authors:  Guido Antonelli; Emanuela Anastasi; Fabrizio Ciprani; Rodolfo J Riveros Cabral; Cristiano Ialongo; Maria R Capobianchi; Ombretta Turriziani; Antonio Angeloni
Journal:  Lancet Microbe       Date:  2021-05-04

4.  Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases.

Authors:  Kaushik Sen; Sudeshna Datta; Arup Ghosh; Atimukta Jha; Abdul Ahad; Sanchari Chatterjee; Sandhya Suranjika; Soumya Sengupta; Gargee Bhattacharya; Omprakash Shriwas; Kiran Avula; Jayasingh Kshatri; Punit Prasad; Rajeeb Swain; Ajay K Parida; Sunil K Raghav
Journal:  Front Immunol       Date:  2021-11-25       Impact factor: 7.561

5.  SARS-CoV-2 Antibody Binding and Neutralization in Dried Blood Spot Eluates and Paired Plasma.

Authors:  Hannah L Itell; Haidyn Weight; Carolyn S Fish; Jennifer K Logue; Nicholas Franko; Caitlin R Wolf; Denise J McCulloch; Jared Galloway; Frederick A Matsen; Helen Y Chu; Julie Overbaugh
Journal:  Microbiol Spectr       Date:  2021-10-20

6.  Insights into household transmission of SARS-CoV-2 from a population-based serological survey.

Authors:  Justin Lessler; Andrew S Azman; Qifang Bi; Isabella Eckerle; Stephen A Lauer; Laurent Kaiser; Nicolas Vuilleumier; Derek A T Cummings; Antoine Flahault; Dusan Petrovic; Idris Guessous; Silvia Stringhini
Journal:  Nat Commun       Date:  2021-06-15       Impact factor: 17.694

7.  Comparison of SARS-CoV-2 Detection by Rapid Antigen and by Three Commercial RT-qPCR Tests: A Study from Martin University Hospital in Slovakia.

Authors:  Zuzana Dankova; Elena Novakova; Maria Skerenova; Veronika Holubekova; Vincent Lucansky; Dana Dvorska; Dusan Brany; Zuzana Kolkova; Jan Strnadel; Sandra Mersakova; Katarina Janikova; Marek Samec; Michal Pokusa; Martin Petras; Miroslava Sarlinova; Ivana Kasubova; Dusan Loderer; Vladimira Sadlonova; Jana Kompanikova; Nina Kotlebova; Adriana Kompanikova; Martina Hrnciarova; Andrea Stanclova; Martina Antosova; Anton Dzian; Vladimir Nosal; Ivan Kocan; Dalibor Murgas; Dusan Krkoska; Andrea Calkovska; Erika Halasova
Journal:  Int J Environ Res Public Health       Date:  2021-07-01       Impact factor: 3.390

8.  Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China.

Authors:  Xia Feng; Jiming Yin; Jiaying Zhang; Yaling Hu; Yabo Ouyang; Shubin Qiao; Hong Zhao; Tong Zhang; Xuemei Li; Lili Zhang; Jie Zhang; Ronghua Jin; Yingmei Feng; Bin Su
Journal:  Front Immunol       Date:  2021-03-15       Impact factor: 7.561

9.  Lateral flow-based nucleic acid detection of SARS-CoV-2 using enzymatic incorporation of biotin-labeled dUTP for POCT use.

Authors:  Saloni Agarwal; Christian Warmt; Joerg Henkel; Livia Schrick; Andreas Nitsche; Frank F Bier
Journal:  Anal Bioanal Chem       Date:  2022-01-19       Impact factor: 4.142

10.  Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after infection.

Authors:  Luísa Canto E Castro; Andreia Gomes; Marta Serrano; Ana Helena Guia Pereira; Rita Ribeiro; Patrícia Napoleão; Inês Domingues; Cláudia Silva; Júlia Fanczal; Ângela Afonso; Andreia Lopes; Ionela Toader; Maria José Rego de Sousa; José Germano Rego de Sousa; Germano de Sousa; Maria M Mota; Bruno Silva-Santos; Marc Veldhoen; Ruy M Ribeiro
Journal:  Eur J Immunol       Date:  2021-11-10       Impact factor: 6.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.